U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H14N2O
Molecular Weight 178.231
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NICOTINE N'-OXIDE, (1'S,2'S)-

SMILES

[H][C@]1(CCC[N@+]1(C)[O-])C2=CC=CN=C2

InChI

InChIKey=RWFBQHICRCUQJJ-JQWIXIFHSA-N
InChI=1S/C10H14N2O/c1-12(13)7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-,12-/m0/s1

HIDE SMILES / InChI
(1'S,2'S)-nicotine-1'-N-oxide is a stereoisomer of nicotine-1'-N-oxide, an oxidation product of S-(-)-nicotine. N-1'-oxidation of nicotine is mediated via flavin-containing monooxygenase. A marked stereoselectivity has been observed in the formation of N-1'-oxide metabolites from nicotine. Mammal hepatic preparations generally produce more the N-1'R,2'S-cis diastereoisomer than N-1'S,2'S-trans diastereoisomer after incubation with S-(-)-nicotine. (1'S,2'S)-nicotine-1'-N-oxide was reported to bind alpha3beta4 neuronal nicotinic acetylcholine receptor. cis- and trans-nicotine-N'-oxides modulate the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.

Originator

Curator's Comment: N-oxides of S-(-)-nicotine have been synthesized and characterized by Phillipson and Handa

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
1985 Dec
Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide.
1993 Nov-Dec
In vitro-in vivo correlations of human (S)-nicotine metabolism.
1995 Aug 8
Diastereospecific kinetics of nicotine N'-oxidation in rat liver microsomes.
1998 Feb
Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.
2008 Sep 29
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
NICOTINE N'-OXIDE, (1'S,2'S)-
Common Name English
PYRIDINE, 3-((1S,2S)-1-METHYL-1-OXIDO-2-PYRROLIDINYL)-
Systematic Name English
(1'S,2'S)-TRANS-NICOTINE-1'-N-OXIDE
Common Name English
NICOTINE-CIS-N-OXIDE
Common Name English
(1S,2S)-SYN-NICOTINE N'-OXIDE
Common Name English
3-((1S,2S)-1-METHYL-1-OXIDO-2-PYRROLIDINYL)PYRIDINE
Systematic Name English
NICOTINE-CIS-N-OXIDE, (+)-
Common Name English
Code System Code Type Description
FDA UNII
6V35J35GP5
Created by admin on Sat Dec 16 09:46:15 GMT 2023 , Edited by admin on Sat Dec 16 09:46:15 GMT 2023
PRIMARY
PUBCHEM
12313859
Created by admin on Sat Dec 16 09:46:15 GMT 2023 , Edited by admin on Sat Dec 16 09:46:15 GMT 2023
PRIMARY
CAS
51095-86-4
Created by admin on Sat Dec 16 09:46:15 GMT 2023 , Edited by admin on Sat Dec 16 09:46:15 GMT 2023
PRIMARY